Literature DB >> 8981382

Visual scan paths are abnormal in deluded schizophrenics.

M L Phillips1, A S David.   

Abstract

One explanation for delusion formation is that they result from distorted appreciation of complex stimuli. The study investigated delusions in schizophrenia using a physiological marker of visual attention and information processing, the visual scan path-a map tracing the direction and duration of gaze when an individual views a stimulus. The aim was to demonstrate the presence of a specific deficit in processing meaningful stimuli (e.g. human faces) in deluded schizophrenics (DS) by relating this to abnormal viewing strategies. Visual scan paths were measured in acutely-deluded (n = 7) and non-deluded (n = 7) schizophrenics matched for medication, illness duration and negative symptoms, plus 10 age-matched normal controls. DS employed abnormal strategies for viewing single faces and face pairs in a recognition task, staring at fewer points and fixating non-feature areas to a significantly greater extent than both control groups (P < 0.05). The results indicate that DS direct their attention to less salient visual information when viewing faces. Future paradigms employing more complex stimuli and testing DS when less-deluded will allow further clarification of the relationship between viewing strategies and delusions.

Entities:  

Mesh:

Year:  1997        PMID: 8981382     DOI: 10.1016/s0028-3932(96)00061-9

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  20 in total

Review 1.  Atypical scanpaths in schizophrenia: evidence of a trait- or state-dependent phenomenon?

Authors:  Sara A Beedie; Philip J Benson; David M St Clair
Journal:  J Psychiatry Neurosci       Date:  2011-05       Impact factor: 6.186

2.  Extraction of social information from gait in schizophrenia.

Authors:  J S Peterman; A Christensen; M A Giese; S Park
Journal:  Psychol Med       Date:  2013-06-28       Impact factor: 7.723

3.  Exploratory eye movements to pictures in childhood-onset schizophrenia and attention-deficit/hyperactivity disorder (ADHD).

Authors:  C Karatekin; R F Asarnow
Journal:  J Abnorm Child Psychol       Date:  1999-02

4.  Impaired fixation to eyes during facial emotion labelling in children with bipolar disorder or severe mood dysregulation.

Authors:  Pilyoung Kim; Joseph Arizpe; Brooke H Rosen; Varun Razdan; Catherine T Haring; Sarah E Jenkins; Christen M Deveney; Melissa A Brotman; R James R Blair; Daniel S Pine; Chris I Baker; Ellen Leibenluft
Journal:  J Psychiatry Neurosci       Date:  2013-11       Impact factor: 6.186

5.  Oxytocin increases eye gaze in schizophrenia.

Authors:  Ellen R Bradley; Alison Seitz; Andrea N Niles; Katherine P Rankin; Daniel H Mathalon; Aoife O'Donovan; Joshua D Woolley
Journal:  Schizophr Res       Date:  2019-08-12       Impact factor: 4.939

6.  The role of alexithymia in reduced eye-fixation in Autism Spectrum Conditions.

Authors:  Geoffrey Bird; Clare Press; Daniel C Richardson
Journal:  J Autism Dev Disord       Date:  2011-11

7.  The categories, frequencies, and stability of idiosyncratic eye-movement patterns to faces.

Authors:  Joseph Arizpe; Vincent Walsh; Galit Yovel; Chris I Baker
Journal:  Vision Res       Date:  2016-12-18       Impact factor: 1.886

8.  Attentional-shaping as a means to improve emotion perception deficits in schizophrenia.

Authors:  Dennis R Combs; Aneta Tosheva; David L Penn; Michael R Basso; Jill L Wanner; Kristen Laib
Journal:  Schizophr Res       Date:  2008-06-27       Impact factor: 4.939

9.  Orienting to social stimuli differentiates social cognitive impairment in autism and schizophrenia.

Authors:  Noah Sasson; Naotsugu Tsuchiya; Robert Hurley; Shannon M Couture; David L Penn; Ralph Adolphs; Joseph Piven
Journal:  Neuropsychologia       Date:  2007-03-15       Impact factor: 3.139

10.  Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis.

Authors:  Philip J Benson; Ute Leonards; Robert M Lothian; David M St Clair; Marco C G Merlo
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.